Houston Matters

Houston Methodist Studying Effects of Emerging Immunotherapy Drug

Posted on · A study underway at Methodist Hospital compares the effects of an immunotherapy drug to a chemotherapy drug on certain lung cancer development. Lung cancer is the second most common malignancy in the United States. We learn more about the study from its principal investigator, Dr. Eric Bernicker, Thoracic Medical Oncologist with the Houston Methodist Cancer Center.

Full Show

Apathy About Police, Charlas, and Immunotherapy: Houston Matters for Thursday, Dec. 18, 2014

Posted on · We learned this past summer about a Houston Police Department staffing study commissioned by the city, which indicated 15,000 burglaries and thefts, 3,000 hit-and-run crashes and 3,000 assaults in 2013 were set aside without follow-up. Houston Police Chief Charles McClelland, at the time, noted “There has never been a time that I have been employed […]